US FDA consults on using patient experience to support approval of novel devices
This article was originally published in SRA
The US Food and Drug Administration is inviting feedback on a draft guideline that explains how the "experience and perspectives of patients" with certain medical devices can be used to support the approval of such products1,2.
You may also be interested in...
US FDA released a final guidance aimed at helping sponsors and other stakeholders interested in using patient-preference information to make their case for a device application. The agency has decided to keep its labeling recommendation in the final guidance despite industry objections.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four guidance documents have been posted on the tracker since its last update.